Intelligo

Private limited company · Snåsa

NEUROZYM BIOTECH AS

ActiveAll other professional, scientific and technical activities n.e.c. (74.990)

Founded
3 Jul 1991
Chief executive
Håkon Brønstad
Business address
Murbræk, 7760 Snåsa

The life line 1997–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 100k.

    Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

    In brief

    NEUROZYM BIOTECH AS is a private limited company in Snåsa, founded in 1991, in the industry all other professional, scientific and technical activities n.e.c.. The chief executive is Håkon Brønstad, and the chair of the board is Maria Brønstad. In 2025 the company had NOK 100k in operating revenue and a net profit of NOK 89k.

    Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

    Overview

    § 01 Latest changes

    2 changes, latest 3 Aug 2026

    • Annual accounts filed 2024 → 2025
    • Godkjente årsregnskap

    Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

    Overview

    § 02 Worth knowing

    None registered

    None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.

    Overview

    § 03 Key figures

    Revenue NOK 100k in 2025

    Revenue

    NOK 100k

    — from 2024

    20232025

    Operating profit

    NOK 48k

    +150.2% from 2024

    20232025

    Net profit

    NOK 89k

    −90.9% from 2024

    20232025

    Equity

    NOK 683k

    +15.1% from 2024

    20232025

    Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

    Finances

    § 04 Where the money comes from and goes

    Financial year 2025

    Of every krone of operating revenue in 2025:

    • Depreciation 5%
    • Other operating costs 48%
    • Left as operating result 48%

    Of the net profit for 2025, NOK 89k stayed in the company. The rest, NOK 1, is an assumed dividend.

    The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

    Finances

    § 05 Financial health

    Equity ratio 14.5%

    RevenueNOK 100k Operating margin47.6% Equity ratio14.5%
    • NEUROZYM BIOTECH AS, 2025
    • Industry median, assumed: NOK 990k · 6.1% · 51.2%

    Equity NOK 683k14% of the assets (NOK 4.7m)

    Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 1,451 companies in 74.990 All other professional, scientific and technical activities n.e.c., not stated by the source.

    Finances

    § 06 Accounts

    28 years, latest 2025

    NOK 1,0002023–25202520242023
    Operating revenue10000
    Operating profit48−95−127
    Profit before tax115−36−71
    Net profit89984−71
    Total assets4,7224,7293,779
    Equity683594−390
    Liabilities4,0394,1364,169

    Source: the Register of Company Accounts, read 15 Nov 2026 · All 28 years →

    Management and ownership

    § 07 Officers

    5 officers now

    The board: 3 members

    Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 5 roles, former ones too →

    Management and ownership

    § 08 Signature, procuration and authorisations

    None registered

    No signature or procuration registered.The Register of Business Enterprises has no provision for the company. Checked 15 Nov 2026.

    Management and ownership

    § 09 Owners

    None registered

    No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.

    Management and ownership

    § 10 Group

    1 subsidiary

    NEUROZYM BIOTECH AS parent company

    Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →

    Management and ownership

    § 11 Portfolio

    None registered

    No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

    Management and ownership

    § 12 Network

    5 connections

    • Person
    • Company

    3 people link NEUROZYM BIOTECH AS to 3 other companies: Eivind Brønstad 1, Håkon Brønstad 1 and Maria Brønstad 1.

    Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →

    Events and registers

    § 13 Events

    2 since 2015

    Events per year

    20152026

    • Notices2
    • Register changes1

    Since 2015: 2 announcements and 1 register change. Most happened in 2024 and 2026.

    Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 9 Nov 2026. Register changes are Intelligo's own observations. · All 2 events →

    Events and registers

    § 14 Notices

    2, latest 11 Sep 2024

    • Godkjente årsregnskap
    • Godkjente årsregnskap

    Source: The Brønnøysund Register Centre's announcements ↗, read 9 Nov 2026 · All 2 →

    Events and registers

    § 15 Charges

    Not fetched yet

    Events and registers

    § 16 Other registers

    Found in 2 of 7

    • The Central Coordinating RegisterRegistered 20 Feb 1995
    • VATNot registered
    • The Register of Business EnterprisesRegistered 12 Aug 1991
    • The Cleaning RegisterNot registered
    • The Register of Staffing AgenciesNot registered
    • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
    • The Financial Supervisory Authority's licence registerNot registered

    Purpose: Utvikle, produsere og selge naturbaserte produkter innen biologisk baserte områder. Selskapet skal også kunne involvere seg i beslektede områder, samt å delta i andre selskaper som driver slik virksomhet.

    Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

    Market

    § 17 Tenders

    None registered

    No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

    Market

    § 18 Vacancies

    None registered

    No vacancies.No open ads at NAV. Checked 15 Nov 2026.

    Market

    § 19 Competitors

    Industry code 74.990

    The companies most like it:

    Compare them

    The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

    Last

    § 20 Questions and answers

    4 questions

    • Who is the chief executive of NEUROZYM BIOTECH AS?
      Håkon Brønstad. § 07
    • What was the revenue in 2025?
      NOK 100k in the company. § 06
    • Where is NEUROZYM BIOTECH AS based?
      Murbræk, 7760 Snåsa.
    • When was NEUROZYM BIOTECH AS founded?
      3 Jul 1991, registered in the Register of Business Enterprises 12 Aug 1991. § 16

    The answers come from the sections linked to, with their sources.

    01Latest changesOverviewContentsClose